Early Phase 1 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a specific type of uterine cancer called endometrioid histology cancer and are scheduled to have a hysterectomy (surgical removal of the uterus) with staging (to determine how far the cancer has spread).
- People who are willing and able to attend all required study visits and complete study assessments, including having access to the internet.
- People who have provided written consent to take part in the study and agreed to the release of their personal health information.
- People who are 18 years of age or older at the time of signing consent.
- People with a body mass index (BMI) of 30 or above (a measure of body weight relative to height, where 30 and above is classified as obese).
- People whose cancer appears to be confined to the uterus only, based on clinical assessment.
- People who are well enough to carry out most daily activities, as measured by standard medical performance scales (confirm with trial site).
Who may not be able to join:
- People who currently have an active infection that requires treatment with medication taken throughout the body (such as antibiotics or antifungals).
- People who are currently pregnant or breastfeeding.
- People who are taking prescription medications or other drugs that may affect the body's metabolism, as determined by the trial doctors.
- People who are currently taking a stimulant medication that affects the brain or nervous system.
- People with current mental health conditions that the trial doctors determine would make participation unsuitable.
- People with known allergies or skin sensitivities (such as hives or eczema) to a class of medications called GIP and GLP-1 receptor agonists.
- People who have type 1 diabetes, a related condition called latent autoimmune diabetes in adults, or who are currently receiving insulin treatment.
- People who have a history of severe low blood sugar episodes, or who are unable to recognise or describe the symptoms of low blood sugar.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bae-Jump Victoria, MD PhD, UNC Lineberger Comprehensive Cancer Center
Phone: +1 919-966-4432
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Proliferation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.